References

Publication Details

1.
Bader JD, Shugars DA, Rozier G, et al Evidence Report: Diagnosis and Management of Dental Caries. Rockville, MD: Agency for Healthcare Research and Quality. 2000. [PMC free article: PMC384376]
2.
Pneumocystis Pneumonia -- Los Angeles MMWR 199645(34):729–33. [PubMed: 8778581]
3.
Gallo RC, Salahuddin SZ, Popovic M, et al Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224:500–3. [PubMed: 6200936]
4.
Fauci AS Field Hearings on AIDS, Senate Appropriations Committee, Subcommittee on Labor, Heath and Human Services, and Education: San Francisco. July 9, 1999.
5.
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR 199241(RR-17):1–19. [PubMed: 1361652]
6.
Recommended infection-control practices for dentistry MMWR 198635(15):237–42. [PubMed: 3083228]
7.
Recommendations for prevention of HIV transmission in health care settings MMWR 198736(SUO2):–. [PubMed: 3112554]
8.
Perspectives in disease prevention and health promotion update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health care settings MMWR 198837(24):377–88. [PubMed: 2836717]
9.
Recommended infection-control practices for dentistry, 1993 MMWR 199342(No. RR-8):1–20. [PubMed: 8502212]
10.
Coulter ID, Marcus M, Freed JR, et al Use of dental care by HIV-infected medical patients J Dent Res 200079(6):1356–61. [PubMed: 10890713]
11.
Marcus M, Freed JR, Coulter ID, et al Perceived unmet need for oral treatment among a national population of HIV-positive medical patients: Social and clinical correlates Am J Public Health 200090(7):1059–63. [PMC free article: PMC1446293] [PubMed: 10897183]
12.
Update: trends in AIDS incidence, deaths, and prevalence -- United States 1996 MMWR 199746(08):165–73. [PubMed: 9072676]
13.
HIV/AIDS Surveillance Report. 1999. pp. –. [PMC free article: PMC325679]
14.
Moniaci D, Greco D, Flecchia G, et al Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions J Oral Pathol Med 199019(10):477–81. [PubMed: 1981079]
15.
Barr CE, Lopez MR, Rua-Dobles A, et al HIV-associated oral lesions: Immunologic, virologic and salivary parameters J Oral Pathol Med 199221(7):295–8. [PubMed: 1355794]
16.
Greenspan JS Sentinels and signposts: The epidemiology and significance of the oral manifestations of HIV disease Oral Dis 19973(Suppl 1):13–7. [PubMed: 9456650]
17.
Lifson AR, Hilton JF, Westenhouse JL, et al Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts AIDS 19948(1):73–9. [PubMed: 8011239]
18.
Glick M, Muzyka BC, Lurie D, et al Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS Oral Surg Oral Med Oral Pathol 199477(4):344–9. [PubMed: 8015797]
19.
Patton LL, McKaig R, Strauss R, et al Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy Oral Surg Oral Med Oral Pathol Oral Radiol Endod 200089(3):299–304. [PubMed: 10710453]
20.
Diz Dios P, Ocampo A, Miralles C, et al Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy Oral Surg Oral Med Oral Pathol Oral Radiol Endod 199987(4):437–41. [PubMed: 10225625]
21.
Schmidt-Westhausen AM, Priepke F, Bergmann FJ, et al Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy J Oral Pathol Med 200029(7):336–41. [PubMed: 10947250]
22.
Tindall B, Cooper DA Primary HIV infection: Host responses and intervention strategies AIDS 19915(1):1–14. [PubMed: 1812848]
23.
Tindall B, Hing M, Edwards P, et al Severe clinical manifestations of primary HIV infection AIDS 19893(11):747–9. [PubMed: 2575913]
24.
Rabeneck L, Popovic M, Gartner S, et al Acute HIV infection presenting with painful swallowing and esophageal ulcers JAMA 1990263(17):2318–22. [PubMed: 2325232]
25.
Masouredis CM, Katz MH, Greenspan D, et al Prevalence of HIV-associated periodontitis and gingivitis in HIV-infected patients attending an AIDS clinic J Acquir Immune Defic Syndr 19925(5):479–83. [PubMed: 1560345]
26.
Riley C, London JP, Burmeister JA Periodontal health in 200 HIV-positive patients J Oral Pathol Med 199221(3):124–7. [PubMed: 1583595]
27.
McKaig RG, Thomas JC, Patton LL, et al Prevalence of HIV-associated periodontitis and chronic periodontitis in a southeastern US study group J Public Health Dent 199858(4):294–300. [PubMed: 10390712]
28.
Melnick SL, Engel D, Truelove E, et al Oral mucosal lesions: Association with the presence of antibodies to the human immunodeficiency virus Oral Surg Oral Med Oral Pathol 198968(1):37–43. [PubMed: 2755688]
29.
Robinson PG, Sheiham A, Challacombe SJ, et al Periodontal health and HIV infection Oral Dis 19973(Suppl 1):149–52. [PubMed: 9456679]
30.
Madigan A, Murray PA, Houpt M, et al Caries experience and cariogenic markers in HIV-positive children and their siblings Pediatr Dent 199618(2):129–36. [PubMed: 8710715]
31.
Coates E, Slade GD, Goss AN, et al Oral conditions and their social impact among HIV dental patients Aust Dent J 199641(1):33–6. [PubMed: 8639112]
32.
Capilouto EI, Piette J, White BA, et al Perceived need for dental care among persons living with acquired immunodeficiency syndrome Med Care 199129(8):745–54. [PubMed: 1875741]
33.
Greene VA, Chu SY, Diaz T, Schable B Oral health problems and use of dental services among HIV-infected adults. Supplement to HIV/AIDS Surveillance Project Group J Am Dent Assoc 1997128(10):1417–22. [PubMed: 9332143]
34.
Mascarenhas AK, Smith SR Factors associated with utilization of care for oral lesions in HIV disease Oral Surg Oral Med Oral Pathol Oral Radiol Endod 199987(6):708–13. [PubMed: 10397663]
35.
Glick M, Abel SN, Muzyka BC, et al Dental complications after treating patients with AIDS J Am Dent Assoc 1994125(3):296–301. [PubMed: 8157842]
36.
Dodson TB Predictors of postextraction complications in HIV-positive patients Oral Surg Oral Med Oral Pathol Oral Radiol Endod 199784(5):474–9. [PubMed: 9394376]
37.
Pankhurst CL, Lewis DA, Clark DT Prophylactic application of an intra-alveolar socket medicament to reduce postextraction complications in HIV-seropositive patients Oral Surg Oral Med Oral Pathol 199477(4):331–44. [PubMed: 8015795]
38.
Okabe K, Nakagawa K, Yamamoto E Factors affecting the occurrence of bacteremia associated with tooth extraction Int J Oral Maxillofac Surg 199524(3):239–42. [PubMed: 7594761]
39.
Conner HD, Haberman S, Collings CK, et al Bacteremias following periodontal scaling in patients with healthy appearing gingiva. J Peridontol. 1967;38:466–72. [PubMed: 5234633]
40.
Dental management of the HIV-infected patient J Am Dent Assoc 1995. Suppl:1–40. [PubMed: 8609315]
41.
Patton LL Hematologic abnormalities among HIV-infected patients: Associations of significance for dentistry Oral Surg Oral Med Oral Pathol Oral Radiol Endod 199988(5):561–7. [PubMed: 10556750]
42.
Hogg RS, Rhone SA, Yip B, et al Antiviral effect of double and triple drug combinations amongst HIV-infected adults: Lessons from the implementation of viral load-driven antiretroviral therapy AIDS 199812(3):279–84. [PubMed: 9517990]
43.
Vernazza PL, Gilliam BL, Flepp M, et al Effect of antiviral treatment on the shedding of HIV-1 in semen AIDS 199711(10):1249–54. [PubMed: 9256943]
44.
Martinez P, Munoz J, Santamaria JM, et al [Acute symptomatic HIV infection. Report of 10 cases]. [Spanish] Enferm Infecc Microbiol 199210(4):205–10. [PubMed: 1606223]
45.
Vanhems P, Dassa C, Lambert J, et al Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection J Acquir Immune Defic Syndr 199921(2):99–106. [PubMed: 10360800]
46.
Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR 199241(RR-17):1–19. [PubMed: 1361652]
47.
Kolokotronis A, Kioses V, Antoniades D, et al Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia Oral Surg Oral Med Oral Pathol 199478(1):41–6. [PubMed: 8078662]
48.
Hilton JF Functions of oral candidiasis episodes that are highly prognostic for AIDS Stat Med 200019(7):989–1004. [PubMed: 10750064]
49.
Ravina A, Ficarra G, Chiodo M, et al Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia J Oral Pathol Med 199625(3):108–11. [PubMed: 9148036]
50.
Feigal DW, Katz MH, Greenspan D, et al The prevalence of oral lesions in HIV-infected homosexual and bisexual men: Three San Francisco epidemiological cohorts AIDS 19915(5):519–25. [PubMed: 1863403]
51.
Schuman P, Ohmit SE, Sobel JD, et al Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group Am J Med 1998104(6):559–64. [PubMed: 9674719]
52.
Begg MD, Panageas KS, Mitchell-Lewis D, et al Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users Oral Surg Oral Med Oral Pathol Oral Radiol Endod 199682(3):276–83. [PubMed: 8884825]
53.
MacPhail LA, Hilton JF, Dodd CL, et al Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis J Acquir Immune Defic Syndr 199612(5):470–6. [PubMed: 8757423]
54.
Stevens DA, Greene SI, Lang OS Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex: Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily Arch Intern Med 1991151(12):2458–64. [PubMed: 1747004]
55.
Schuman P, Capps L, Peng G, et al Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection: A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS Ann Intern Med 1997126(9):689–96. [PubMed: 9139554]
56.
Saag MS, Fessel WJ, Kaufman CA, et al Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients Aids Res Hum Retroviruses 199915(16):1413–7. [PubMed: 10555103]
57.
Hunter KD, Gibson J, Lockhart P, et al Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients Oral Surg Oral Med Oral Pathol Oral Radiol Endod 199885(5):558–64. [PubMed: 9619674]
58.
Tumbarello M, Tacconelli E, Caldarola G, et al Fluconazole resistant oral candidiasis in HIV-infected patients Oral Dis 19973(Suppl 1):110–2. [PubMed: 9456668]
59.
Sangeorzan JA, Bradley SF, He X, et al Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994;97:339–46. [PubMed: 7942935]
60.
Maenza JR, Keruly JC, Moore RD, et al Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients J Infect Dis 1996173(1):219–25. [PubMed: 8537662]
61.
Boken DJ, Swindells S, Rinaldi MG Fluconazole-resistant Candida albicans Clin Infect Dis 199317(6):1018–21. [PubMed: 8110924]
62.
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA) MMWR 199948(RR-10):1–59, 61-6. [PubMed: 10499670]
63.
Revankar SG, Kirkpatrick WR, McAtee RK, et al A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: Clinical outcomes and development of fluconazole resistance. Am J Med. 1998;105:7–11. [PubMed: 9688014]
64.
Lohr KN, Carey TS Assessing 'best evidence': Issues in grading the quality of studies for systematic reviews Jt Comm J Qual Improv 199925(9):470–9. [PubMed: 10481816]
65.
Begg C, Cho M, Eastwood S, et al Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA 1996276(8):637–9. [PubMed: 8773637]
66.
Lijmer JG, Mol BW, Heisterkamp S, et al Empirical evidence of design-related bias in studies of diagnostic tests JAMA 1999282(11):1061–6. [PubMed: 10493205]
67.
Little JW Dental management of the medically compromised patient. St. Louis: Mosby. 1997. [PMC free article: PMC176006]
68.
Scully C, McCarthy G Management of oral health in persons with HIV infection Oral Surg Oral Med Oral Pathol 199273(2):215–25. [PubMed: 1312692]
69.
Glick M Clinical protocol for treating patients with HIV disease Gen Dent 199038(6):418–25. [PubMed: 2151446]
70.
Cooper H Root canal treatment on patients with HIV infection Int Endod J 199326(6):369–71. [PubMed: 8144247]
71.
Barr CE, Rua-Dobles A, Puig N Dental care for HIV-positive patients Spec Care Dentist 19899(6):191–4. [PubMed: 2533728]
72.
Osborn TP, Frederickson GJ, Small IA, et al A prospective study of complications related to mandibular third molar surgery J Oral Maxillofac Surg 198543(10):767–9. [PubMed: 2995624]
73.
Overholser CD, Peterson DE, Bergman SA, et al Dental extractions in patients with acute nonlymphocytic leukemia J Oral Maxillofac Surg 198240(5):296–8. [PubMed: 6211528]
74.
Robinson PG, Cooper H, Hatt J Healing after dental extractions in men with HIV infection Oral Surg Oral Med Oral Pathol 199274(4):426–30. [PubMed: 1408013]
75.
Porter SR, Scully C, Luker J Complications of dental surgery in persons with HIV disease. Oral Surg Oral Med Oral Pathol. 1993;75:165–7. [PubMed: 8426715]
76.
Dodson TB HIV status and the risk of post-extraction complications J Dent Res 199776(10):1644–52. [PubMed: 9326896]
77.
Dodson TB, Perrott DH, Gongloff RK, et al Human immunodeficiency virus serostatus and the risk of postextraction complications International J Oral Maxillofac Surg 199423(2):100–3. [PubMed: 8035049]
78.
Colebunders R, Ryder R, Francis H, et al Seroconversion rate, mortality, and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire J Infect Dis 1991164(3):450–6. [PubMed: 1869835]
79.
Margiotta V, Campisi G, Mancuso S, et al HIV nfection: Oral lesions, CD4+ cell count and viral load in an Italian study population J Oral Pathol Med 199928(4):173–7. [PubMed: 10235371]
80.
Lamster IB, Begg MD, Mitchell-Lewis D, et al Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions Oral Surg Oral Med Oral Pathol 199478(2):163–74. [PubMed: 7936584]
81.
Melnick SL, Hannan P, Decher L, et al Increasing CD8+ T lymphocytes predict subsequent development of intraoral lesions among individuals in the early stages of infection by the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1991;4:1199–1207. [PubMed: 1682473]
82.
Howell RB, Jandinski JJ, Palumbo P, et al Oral soft tissue manifestations and CD4 lymphocyte counts in HIV-infected children Pediatr Dent 199618(2):117–20. [PubMed: 8710712]
83.
Kirby AJ, Munoz A, Detels R, et al Thrush and fever as measures of immunocompetence in HIV-1-infected men J Acquir Immune Defic Syndr 19947(12):1242–9. [PubMed: 7965635]
84.
Schuman P, Sobel JD, Ohmit SE, et al Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group Clin Infect Dis 199827(5):1161–7. [PubMed: 9827263]
85.
Phelan JA, Begg MD, Lamster IB, et al Oral candidiasis in HIV infection: Predictive value and comparison of findings in injecting drug users and homosexual men J Oral Pathol Med 199726(5):237–43. [PubMed: 9178176]
86.
Husak R, Garbe C, Orfanos CE Oral hairy leukoplakia in 71 HIV-seropositive patients: Clinical symptoms, relation to immunologic status, and prognostic significance J Am Acad Dermatol 199635(6):928–34. [PubMed: 8959952]
87.
Chiang CP, Chueh LH, Lin SK, et al Oral manifestations of human immunodeficiency virus-infected patients in Taiwan J Formos Med Assoc 199897(9):600–5. [PubMed: 9795527]
88.
Patton LL, McKaig RG, Strauss RP, et al Oral manifestations of HIV in a southeast USA population Oral Dis 19984(3):164–9. [PubMed: 9972166]
89.
Patton LL, McKaig RG, Eron JJ, et al Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load AIDS 199913(15):2174–6. [PubMed: 10546876]
90.
Marriott DJ, Jones PD, Hoy JF, et al Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study Med J Aust 1993158(5):312–6. [PubMed: 8097273]
91.
Leen CL, Dunbar EM, Ellis ME, et al Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: A double-blind placebo-controlled study [published erratum appears in J Infect Dis 1990;21(2):183] J Infect 199021(1):55–60. [PubMed: 2200826]
92.
Just-Nubling G, Gentschew G, Meissner K, et al Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients Eur J Clin Microbiol Infect Dis 199110(11):917–21. [PubMed: 1794360]
93.
Cauda R, Tacconelli E, Tumbarello M, et al Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: A prospective case-control study J Acquir Immune Defic Syndr 199921(1):20–5. [PubMed: 10235510]
94.
Cassone A, De Bernardis F, Torosantucci A, et al In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors J Infect Dis 1999180(2):448–53. [PubMed: 10395861]
95.
Freedberg KA, Scharfstein JA, Seage GR, et al The cost-effectiveness of preventing AIDS-related opportunistic infections [published erratum appears in JAMA 1999;281(21):1989] JAMA 1998279(2):130–6. [PubMed: 9440663]
96.
Phillips P, De Beule K, Frechette G, et al A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS Clin Infect Dis 199826(6):1368–73. [PubMed: 9636865]
97.
De Wit S, Weerts D, Goossens H, Clumeck N Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS Lancet 19891(8641):746–8. [PubMed: 2564563]
98.
De Repentigny L, Ratelle J, Baril JG, et al Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group Chemotherapy 199642(5):374–83. [PubMed: 8874977]
99.
Graybill JR, Vazquez J, Darouiche RO, et al Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients Am J Med 1998104(1):33–9. [PubMed: 9528717]
100.
Pons V, Greenspan D, Lozada-Nur F, et al Oropharyngeal candidiasis in patients with AIDS: Randomized comparison of fluconazole versus nystatin oral suspensions Clin Infect Dis 199724(6):1204–7. [PubMed: 9195083]
101.
Pons V, Greenspan D, Debruin M Therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group. J Acquir Immune Defic Syndr . 1993;6:1311–6. [PubMed: 8254467]
102.
Murray PA, Koletar SL, Mallegol I, et al Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients Clin Ther 199719(3):471–80. [PubMed: 9220211]
103.
Flynn PM, Cunningham CK, Kerkering T, et al Oropharyngeal candidiasis in immunocompromised children: A randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group J Pediatr 1995127(2):322–8. [PubMed: 7636666]
104.
Koletar SL, Russell JA, Fass RJ, et al Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus Antimicrob Agents Chemother 199034(11):2267–8. [PMC free article: PMC172036] [PubMed: 2073120]
105.
De Wit S, O'Doherty E, Edwards J, et al Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: A phase I study Antimicrob Agents Chemother 199842(4):903–6. [PMC free article: PMC105564] [PubMed: 9559805]
106.
Hernandez-Sampelayo T Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group Eur J Clin Microbiol Infect Dis 199413(4):340–4. [PubMed: 8070443]
107.
Nyst MJ, Perriens JH, Kimputu L, et al Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients Ann Soc Belg Med Trop 199272(1):45–52. [PubMed: 1567268]
108.
De Wit S, O'Doherty E, De Vroey C, et al Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis J Intern Med Res 199826(3):159–70. [PubMed: 9718471]
109.
European Community Clearinghouse on Oral Problems Related to HIV Infection and World Health Organization Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med. 1993;22:289–91. [PubMed: 8229864]
110.
Greenspan JS, Barr CE, Sciubba JJ, et al Oral manifestations of HIV infection: Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group Oral Surg Oral Med Oral Pathol 199273(2):142–4. [PubMed: 1532234]
111.
Ramos-Gomez FJ, Flaitz C, Catapano P, et al Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative workgroup on Oral Manifestations of Pediatric HIV Infection J Clin Pediatr Dent 199923(2):85–96. [PubMed: 10204447]